Bayer is collaborating with Israeli biotech company Compugen to develop drugs that helps the immune system fight cancer.
Bayer is collaborating with Israeli biotech company Compugen to develop drugs that helps the immune system fight cancer.
Leverkusen, Germany-based Bayer is paying $10 million upfront in a preclinical research deal that potentially could be worth more than $500 million for Compugen
The Danish firm's atopic dermatitis drug is holding its own despite strong competition from Sanofi/Regeneron’s Dupixent.
Lilly saw solid growth for its business in Japan last year on the back of several new launches and is building its obesity and Alzheimer's portfolios in the country.
Deal Snapshot: The Danish drugmaker is partnering with GPCR drug discovery expert Septerna to develop multiple small molecules for cardiometabolic targets.
